Skip to content

An Investigation into the role of Matrix Metalloproteinases (MMPs) in Lower Limb Vascular Restenosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN35955220
Enrollment
270
Registered
2006-09-29
Start date
2005-07-18
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Cardiovascular Surgery Cardiovascular

Interventions

Patients under the care of the Cambridge Vascular Unit undergoing femoro-popliteal angioplasty or femoro-popliteal/tibial bypass will be eligible for the study. The indication for intervention will be

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Serum samples collected at the time of vascular intervention (radiologist or surgeon). Follow up samples by vascular research fellow. Arterial wall and vein biopsies taken at the time of surgery by operating surgeon.

Exclusion criteria

Exclusion criteria: 1. Patient unable to give informed consent 2. Age < 18 years 3. Pregnancy, planned pregnancy 4. Life expectancy less than 12 months 5. Inability to monitor the angioplasty site or graft with ultrasound for stenosis 6. Unable to take SDD (ie allergic reaction) or currently taking tetracyclines 7. Unable to take adjuvant treatment with antiplatelet/anticoagulant agent and statin

Design outcomes

Primary

MeasureTime frame
1. MMP activities SDD versus placebo 2. CRP levels 3. Endothelial function and re-stenosis 4. Arterial wall stiffness and re-stenosis.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026